Effect of serum diamine oxidase activity derived from response to chemotherapy on adverse events and serum amino acid concentrations for esophageal cancer.

被引：0
|
作者：
Sato, Yuta [1 ]
Tajima, Jesse Yu
Tanaka, Yoshihiro
Matsuhashi, Nobuhisa
机构：
[1] Gifu Univ Hosp, Dept Gastroenterol Surg, Gifu, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 23_SUPPL期
关键词：
261-566-148; 3282-3306-9677; 261-492-199-2823; 7; 3; 1634; 2002; 54; 256; 62; 2; 1;
D O I：
10.1200/JCO.2024.42.23_suppl.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 8 条
  • [1] Serum diamine oxidase activity derived from response to chemotherapy affects adverse events and serum amino acid levels
    Yuta Sato
    Yoshihiro Tanaka
    Takeharu Imai
    Naoki Okumura
    Nobuhisa Matsuhashi
    Takao Takahashi
    Toshio Shimokawa
    Kazuhiro Yoshida
    Supportive Care in Cancer, 2022, 30 : 9369 - 9377
  • [2] Serum diamine oxidase activity derived from response to chemotherapy affects adverse events and serum amino acid levels
    Sato, Yuta
    Tanaka, Yoshihiro
    Imai, Takeharu
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Shimokawa, Toshio
    Yoshida, Kazuhiro
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9369 - 9377
  • [3] Effect of dietary fatty acid and micronutrient intake/energy ratio on serum diamine oxidase activity in healthy women
    Miyoshi, Makoto
    Ueno, Manami
    Matsuo, Mari
    Hamada, Yasuhiro
    Takahashi, Michiko
    Yamamoto, Masashi
    Yamamoto, Ikuko
    Mikajiri, Reiko
    Tabuchi, Satoko
    Wakida, Kumiko
    Yamanishi, Misa
    Hirai, Midori
    Usami, Makoto
    NUTRITION, 2017, 39-40 : 67 - 70
  • [4] Serum markers to monitor response to zoledronic acid in patients with bone metastases from breast cancer.
    Mercatali, L.
    Ibrahim, T.
    Sacanna, E.
    Ricci, R.
    Scarpi, E.
    Fabbri, F.
    Serra, P.
    Tison, C.
    Amadori, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Potential role of serum proteome in predicting immune-related adverse events from immunotherapy in non-small cell lung cancer.
    Nam, Myungwoo
    Kim, Leeseul
    Cheng, William
    Bae, William H.
    Hwang, Jin Young
    Choi, Yoonhee
    Lee, Yeun Ho
    Hur, Won Kyung
    Jung, Chan Mi
    Cho, Heayoon S.
    Chae, Young Kwang
    CANCER RESEARCH, 2021, 81 (13)
  • [6] Potential role of serum proteome in predicting immune-related adverse events from immune checkpoint inhibitors in non-small cell lung cancer.
    Kim, Leeseul
    Chae, Young Kwang
    Jung, Chan Mi
    Yu, Emma
    Lee, Alice Daeun
    Choi, Yoonhee
    Jung, Hojung
    Park, Inae
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Asparaginase (ASNase) activity, amino acid serum concentrations and clinical outcome in pediatric patients with higher risk acute lymphoblastic leukemia (HR ALL): A report from CCG-1961.
    Panosyan, EH
    Grigoryan, RS
    Avramis, LA
    Jaques, JD
    Seibel, NL
    Ettinger, LJ
    Gaynon, PS
    Siegel, SE
    Fingert, HJ
    Avramis, VI
    BLOOD, 2003, 102 (11) : 378A - 378A
  • [8] Serum levels of immune markers associated with pathological complete response (pCR) and immune-related adverse events (irAEs) in early-stage breast cancer patients receiving immune checkpoint inhibitor plus chemotherapy in the I-SPY 2 trial
    Alkhafaji, Silver
    Wolf, Denise M.
    Basu, Amrita
    Brown-Swigart, Lamorna
    Nanda, Rita
    Liu, Minneta
    Hirst, Gillian L.
    Esserman, Laura J.
    van't Veer, Laura
    Campbell, Michael
    CANCER RESEARCH, 2024, 84 (03)
1